Position in BNTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$390,810
+$26,402 QoQ
Shares Held
4,200
+2.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#161
of 282 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arlington Capital Management, Inc. holds $788,194 across 2 Biotechnology names. BNTX ranks #2 (49.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
800 | $397,384 | |
| 2 | BNTX |
BioNTech SE
This page
|
4,200 | $390,810 |
All Filings in BNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390,810 | 4,200 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $364,408 | 4,100 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $247,520 | 2,600 | Shares | Sole | 2026-01-06 | |
| 2024-09-30 | $452,157 | 3,807 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $208,936 | 2,600 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $202,950 | 2,200 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $211,080 | 2,000 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||